---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-453635"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2026-11-09T21:16:37+00:00"
generated_at: "2026-11-09T21:18:10.300734+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Stryker expands board to 12, elects Quest Diagnostics CEO Jim Davis effective Jan 1, 2027

## Summary
- Board increased authorized directors from 11 to 12 and elected James E. Davis to fill the vacancy; term begins January 1, 2027.
- Davis has been CEO and President of Quest Diagnostics since November 2022 and Chairman of the Quest board since April 2023.
- Prior roles: CEO of InSightec, two decades at GE including five years leading GE's MRI business, and earlier McKinsey client work.
- Not appointed to any board committee at this time; pay will match other non-employee directors per the 2026 proxy statement.
- CEO Kevin Lobo cited Davis's healthcare experience and medical-technology understanding as the rationale for the nomination.

## SEC filing metadata
- accession: 0001193125-26-453635
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2026-11-09T21:16:37+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000119312526453635/0001193125-26-453635-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000119312526453635/d101928d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-453635
- JSON: https://secwatch.observer/filing/0001193125-26-453635.json
- Plain text: https://secwatch.observer/filing/0001193125-26-453635.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.